Back to Journals » Clinical Ophthalmology » Volume 13

Corrigendum

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

         
Total article views   Abstract views HTML views PDF downloads Totals
3,775 Dovepress* 3,425 224+ 1,332 3,649
PubMed Central* 0 126 44 126
Totals 3,425 350 1,376 3,775
*Since 24 January 2019
+Since July 2016

View citations on PubMed Central and Google Scholar